This week, 12 Medical Devices stocks are improving their overall ratings on . Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).
This week, HeartWare International (NASDAQ:) is showing significant improvement as the company’s rating hops from a C (“hold”) to a B (“buy”). HeartWare International is developing a range of implantable mechanical circulatory assist devices or heart pumps, used for the treatment of congestive heart failure. .
This week, Endologix’s (NASDAQ:) ratings are up from a C last week to a B. Endologix develops, manufactures, sells, and markets minimally invasive treatments for vascular diseases. .
Neogen Corp. (NASDAQ:) improves from a C to a B rating this week. Neogen develops and markets products and services dedicated to food and animal safety. .
C.R. Bard (NYSE:) is seeing ratings go up from a C last week to a B this week. C. R. Bard is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. .
Conceptus (NASDAQ:) is progressing from last week’s rating of B (“buy”) as the company improves to an A (“strong buy”) this week. Conceptus designs, develops, and markets minimally invasive devices for reproductive medical applications primarily in the United States, France, and rest of Europe. .
ArthroCare (NASDAQ:) shows solid improvement this week. The company’s rating rises from a C to a B. ArthroCare is a multi-business medical device Company that develops, manufactures and markets minimally invasive surgical products, many of which are based on its patented Coblation(r) technology. .
The rating of Symmetry Medical
(NYSE:) moves up this week, rising from a C to a B. Symmetry Medical provides global orthopedic device manufacturers with implants and related instruments and cases. .
Thoratec (NASDAQ:) boosts its rating from a C to a B this week. Thoratec is involved in the development, manufacture and marketing of proprietary medical devices used for circulatory support. .
This is a strong week for Cutera (NASDAQ:). The company’s rating climbs to B from the previous week’s C. Cutera is a global provider of laser and other light-based aesthetic systems for practitioners worldwide. Shares of CUTR have increased 18.6% over the past month, better than the 7.2% decrease the Nasdaq has seen over the same period of time. .
This week, IMRIS Inc. (NASDAQ:) pushes up from a C to a B rating. IMRIS is a medical imaging company that focuses on bringing magnetic resonance imaging (MRI) to surgical procedures. .
Winner Medical Group (NASDAQ:) boosts its rating from a B to a A this week. Winner Medical Group engages in the research, development, manufacture, and marketing of cotton-base medical dressings and medical disposables. .
This week, TearLab (NASDAQ:) pushes up from a B to a A rating. TearLab is an in-vitro diagnostics company. .
Louis Navellier’s proprietary stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool .
